Biopharmaceutical company Novavax, Rockville, Md., named Dr. Louis Fries III vice president of clinical and medical affairs.
Novavax names Fries clinical VP
Fries previously was director of global clinical development for GlaxoSmithKline Biologicals, North America, according to a Novavax news release. He served as vice president of clinical and medical affairs at Canadian vaccine manufacturer ID Biomedical Corp. before GlaxoSmithKline acquired that company (PDF) in 2005. Fries, who is board-certified in internal medicine and infectious diseases, also is a former senior director of clinical research at Nabi Pharmaceuticals, Rockville. His age was unavailable at deadline.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.